Vicore Pharma Holding AB operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vicore Pharma Holding AB with three other
pharmaceutical manufacturers in Europe:
NUTEX Investments Plc
sales of 8.76 million Hungarian Forints [US$34,251.60 ]
Futura Medical PLC
of the United Kingdom
(£362,727.00 [US$505,895.35 ]
of which 100%
was Pharmaceuticals), and
Oasmia Pharmaceutical AB
(172,000.00 Swedish Kronor [US$20,187.64 ]
During the year ended December of 2017, sales at
Vicore Pharma Holding AB were SEK 932,000.00 (US$109.39 thousand).
increase of 9.4%
versus 2016, when the company's sales were SEK 852,000.00 .